Topocecan is a semisynthetic derivative of Camptothecin (Cat.No.1039) that displays antineoplastic activity. DNA topoisomerase I inhibitor; induces rapid apoptotic death in human B-lineage acute lymphoblastic leukemia (ALL) cells. Improves survival in three mouse models of poor prognosis.